Be a Smart Investor
Thursday, May 25, 2017
Aerie Pharmaceuticals Inc. (AERI) Has Leaped To A New High On Study Results
Aerie Pharmaceuticals Inc. (AERI) announced after the close Wednesday that its Phase 3 study of Roclatan achieved its primary efficacy endpoint.
from RTT - Hot Stocks http://ift.tt/2qZrusL
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment